CIK 0000914475
- Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330525145
- Phone
- +1 858-617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-08 | Bozigian Haig P. Chief Development Officer | Sale | −824 | $116.85 | $96K | 154,934 |
| 2021-02-08 | Bozigian Haig P. Chief Development Officer | Sale | −1,395 | $116.78 | $163K | 156,189 |
| 2021-02-08 | Bozigian Haig P. Chief Development Officer | Sale | −1,623 | $116.79 | $190K | 157,651 |
| 2021-02-08 | Bozigian Haig P. Chief Development Officer | Grant or award · Stock Option | +3,188 | 3,188 | ||
| 2021-02-08 | Bozigian Haig P. Chief Development Officer | Grant or award · Restricted Stock Unit | +532 | 532 | ||
| 2021-02-08 | BENEVICH ERIC Chief Commercial Officer | Sale | −845 | $116.89 | $99K | 18,018 |
| 2021-02-08 | BENEVICH ERIC Chief Commercial Officer | Sale | −1,395 | $116.76 | $163K | 19,273 |
| 2021-02-08 | BENEVICH ERIC Chief Commercial Officer | Sale | −2,030 | $116.84 | $237K | 21,099 |
| 2021-02-08 | BENEVICH ERIC Chief Commercial Officer | Grant or award · Stock Option | +44,632 | 44,632 | ||
| 2021-02-08 | BENEVICH ERIC Chief Commercial Officer | Grant or award · Restricted Stock Unit | +7,439 | 7,439 | ||
| 2021-02-08 | Cooke Julie Chief Human Resources Officer | Sale | −425 | $116.76 | $50K | 12,915 |
| 2021-02-08 | Cooke Julie Chief Human Resources Officer | Sale | −913 | $116.72 | $107K | 13,737 |
| 2021-02-08 | Cooke Julie Chief Human Resources Officer | Grant or award · Stock Option | +31,880 | 31,880 | ||
| 2021-02-08 | Cooke Julie Chief Human Resources Officer | Grant or award · Restricted Stock Unit | +5,314 | 5,314 | ||
| 2021-02-08 | ROBERTS EIRY Chief Medical Officer | Sale | −740 | $116.67 | $86K | 17,231 |
| 2021-02-08 | ROBERTS EIRY Chief Medical Officer | Sale | −1,623 | $116.83 | $190K | 18,693 |
| 2021-02-08 | ROBERTS EIRY Chief Medical Officer | Grant or award · Stock Option | +44,632 | 44,632 | ||
| 2021-02-08 | ROBERTS EIRY Chief Medical Officer | Grant or award · Restricted Stock Unit | +7,439 | 7,439 | ||
| 2021-02-08 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −756 | $116.89 | $88K | 30,437 |
| 2021-02-08 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −1,490 | $116.74 | $174K | 31,597 |
Page 60 of 62 · 1,221 trades